1. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
   Simone Brivio et al, 2017, WJH CrossRef
2. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
   Simone Brivio et al, 2015, JCM CrossRef
3. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment
   Antonio Garcia-Gomez et al, 2018, Clinical Immunology CrossRef
4. Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
   Si Sun et al, 2018, Cancer Sci CrossRef
5. Epigenetics in ovarian cancer: premise, properties, and perspectives.
   Qilian Yang et al, 2018, Mol Cancer CrossRef
6. Mimicking the tumor microenvironment: Fibroblasts reduce miR-29b expression and increase the motility of ovarian cancer cells in a co-culture model
   Mariana Medeiros et al, 2019, Biochemical and Biophysical Research Communications CrossRef
7. Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling.
   Huan Yan et al, 2016, Biochem Biophys Res Commun CrossRef
8. Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
   Marvin Sylvestre et al, 2019, Epigenomics CrossRef
9. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
   Lan G. Coffman et al, 2016, Oncotarget CrossRef
10. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
    Tamás Barbai et al, 2015, Oncotarget CrossRef
11. Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
    Tiansheng Li et al, 2020, J Exp Clin Cancer Res CrossRef
12. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer
    Se-Ra Lee et al, 2015, Clin Cancer Res CrossRef
13. Cancer epigenetics: Past, present and future.
    Jae Eun Lee et al, 2021, Semin Cancer Biol CrossRef
14. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Xiangjiao Meng et al, 2014, Radiat Oncol CrossRef
15. Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
    Hui Sun et al, 2022, BMC Cancer CrossRef
16. Fibroblasts as Turned Agents in Cancer Progression
    Robert Wieder, 2023, Cancers CrossRef
17. Epigenetic regulation and therapeutic targets in the tumor microenvironment
    Zhuojun Xie et al, 2023, Mol Biomed CrossRef
18. null
    Hue Vu Thi et al, 2024 CrossRef